Navigation Links
New Fall Allergy Capitals(TM) Reveal the Most Challenging Cities for Allergy Sufferers
Date:10/2/2009

lergy medications used per patient
  • Number of allergy specialists per patient
  • This year's report indicates that more than fifty percent of the United States' population lives in one of the 100 Fall Allergy Capital cities. However, McAllen, TX is ranked number one this year due to a higher-than-average pollen score, higher use of allergy medications per person, and lower-than-average access to allergy specialists, compared to other cities on the list.(1)

    About Allergies

    More than 36 million Americans suffer from indoor and outdoor allergic rhinitis, also known as upper respiratory allergies.(2C) Allergies are caused when a person's immune system overreacts to normally harmless substances.(3B) These substances are often referred to as triggers.(3C) People can encounter indoor and outdoor allergy triggers anytime throughout the year that can lead to allergy symptoms. (3C) Indoor allergies can occur year-round and are triggered by substances such as mold, dust mites, and pet dander.(3D) These allergens are often inhaled through the nose and mouth, putting the allergens in contact with the immune cells in the lining of the nose, mouth, throat, and airways of the lungs causing an allergic response. (3D) Similarly, outdoor allergies can occur when outdoor allergens such as pollen from grasses, weeds and trees are inhaled through the nose and mouth into the lungs causing an allergic response.(3E) Those who suffer from outdoor allergies are often affected by allergies in the spring and fall.(3F) Symptoms for both indoor and outdoor allergies can include itchy, watery eyes, itchy nose or throat,(2F) sneezing(2G) and runny nose.(2F)

    About The Asthma and Allergy Foundation of America

    The Asthma and Allergy Foundation of America, a not-for-profit organization founded in 1953, is the leading patient organization for people with asthma and allergies, and the oldest and largest asthm
    '/>"/>

    SOURCE The Asthma and Allergy Foundation of America (AAFA)
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
    2. Circassias Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients
    3. Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment
    4. Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology
    5. Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology
    6. American Lung Association Study Finds No Evidence of Depression or Suicide Linked to Asthma and Allergy Drug Montelukast
    7. Study Says Allergy Shots Help Children, Reduce Health Care Costs
    8. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
    9. NASA Research Reveals Major Insight Into Evolution of Life on Earth
    10. Northern California Cancer Centers First-of-Its-Kind Research Reveals Low Socioeconomic Status Often Equals Poor Chance of Lymphoma Survival
    11. New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/30/2014)... , Oct. 30, 2014 Boston Scientific ... participate in the 2014 Credit Suisse Annual Healthcare Conference ... , AZ.  Dan Brennan , executive vice ... about the company beginning at approximately 8:00 a.m. PT ... A live webcast of the presentation and question and ...
    (Date:10/30/2014)... 2014  Nektar Therapeutics (Nasdaq: NKTR ) ... ended September 30, 2014 on Thursday, November 6, 2014, ... Robin , president and chief executive officer, will host ... 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... audio-only Webcast of the conference call can be accessed ...
    (Date:10/30/2014)...   Auxilium Pharmaceuticals , Inc. (NASDAQ: ... company, today announced financial results for the third ... important corporate, commercial, regulatory and clinical development updates ... very pleased with the continued momentum and strong ... portfolio this quarter, especially the XIAFLEX franchise, which ...
    Breaking Medicine Technology:Boston Scientific To Participate In 2014 Credit Suisse Annual Healthcare Conference 2Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets 2Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 2Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 3Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 4Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 5Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 6Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 7Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 8Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 9Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 10Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 11Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 12Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 13Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 14Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 15Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 16Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 17Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 18Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 19Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 20Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 21Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 22
    ... in Combination with CRESTOR (rosuvastatin calcium) Improved LDL, HDL ... ... SEATTLE, May 31 New Phase III data showed,that in ... AstraZeneca,s CRESTOR(R) (rosuvastatin,calcium) led to greater improvements than the corresponding ...
    ... Annual Meeting -, SOUTH SAN FRANCISCO, ... Pharmaceuticals, Inc. (Nasdaq: PARD ), a ... safety and,efficacy data from its ongoing Phase ... docetaxel and prednisone, the standard of care ...
    Cached Medicine Technology:Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids 2Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids 3Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids 4Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 2Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 3Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 4
    (Date:10/30/2014)... Paramount Rx, a full-service prescription benefits manager ... help people save money through its innovative discount card ... drugs in the new health care system, the Paramount ... the relationship between consumers, businesses and the pharmacy industry. ... face today with medical costs is the rising price ...
    (Date:10/30/2014)... Canada (PRWEB) October 30, 2014 Home ... area’s leading provider of non-medical, in-home senior care, is ... to increased brain health. , The study, performed by ... ages of 60 and 78 over a week-long period ... opposed to daily physical activity. By examining the structural ...
    (Date:10/30/2014)... October 30, 2014 REV'D Provision Co. ... now available through a unique service called, The ... to empower the everyday athlete. The Feed has taken ... and created a system to pass that information on ... REV’D® is now available on The Feed!” says REV’D® ...
    (Date:10/30/2014)... When it comes to heart disease, a new study finds ... they have symptoms that spell trouble. "The main danger ... more severe or advanced stage of heart disease, there are ... Fulbright Scholar and research fellow at the Harvard School of ... and Stroke Foundation of Canada. In the study, researchers ...
    (Date:10/30/2014)... a low-carb, high-fat diet could help control epilepsy that ... A review of five studies found that a ... like bacon, eggs, heavy cream, butter, fish and green ... doesn,t improve with medication. "We need new treatments ... seizures are not stopped by medications," study co-author Dr. ...
    Breaking Medicine News(10 mins):Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 3Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 2Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 3Health News:Nutrition Experts at TheFeed.com Get REV'D 2Health News:Nutrition Experts at TheFeed.com Get REV'D 3Health News:Women Often Ignore Signs of Heart Trouble 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 3
    ... , TUESDAY, June 29 (HealthDay News) -- Scientists report ... older women by causing certain genetic mutations. The study ... National Cancer Institute. . Previous research has indicated that ... develop colorectal cancer than those who never smoked, according to ...
    ... ... employers who want to provide health benefits and control costs., , ... Minneapolis, MN (PRWEB) June 29, 2010 ... largest independent insurance and employee benefits brokers in the Midwest, to offer customized defined ...
    ... ... Symptom Checker, a new online tool to help users evaluate their child,s symptoms. The tool ... ... if your child develops a fever, cough, vomiting, rash, sore throat or head injury? A ...
    ... HealthDay Reporter , TUESDAY, June 29 (HealthDay News) -- Type ... that continuously monitored their blood sugar levels had better control ... clinical trial finds. , , Researchers divided 485 people ... multiple daily insulin injections and tested their blood sugar throughout ...
    ... the Ohio State University Comprehensive Cancer Center-Arthur G. ... Institute (OSUCCC-James) have discovered how a substance that ... can block the proliferation of cancer cells. ... may have anticancer effects and other health benefits, ...
    ... powerful and highly addictive psychostimulant that is toxic to ... many parts of the United States. The National Institute ... Americans have tried methamphetamine, while more than 1.4 million ... the drug can lead to devastating medical, psychological and ...
    Cached Medicine News:Health News:Bloom Health and Christensen Group Partner Together to Deliver Innovative Solution 2Health News:AAP Offers New Online Pediatric Symptom Checker on HealthyChildren.org 2Health News:Insulin Pump With Blood Sugar Sensor May Improve on Injections 2Health News:Insulin Pump With Blood Sugar Sensor May Improve on Injections 3Health News:Study shows how dietary supplement may block cancer cells 2Health News:Dental school gets $1.86 million from NIH for study of methamphetamine's effect on oral health 2
    ...
    It is a magnifying headlight perfect for all applications and procedures where clear magnification and a natural white light increase accuracy and productivity....
    It is lightweight and portable headlight option for office exam room. It offers complete comfort and portability....
    Solarc surgical headlight is durable, comfortable, lightweight and delivers the bright, white light expected from a xenon system, but at a fraction of the cost....
    Medicine Products: